Is HRT safe? Side effects, personal risks and warning signs

Start with benefit as well as risk

Systemic HRT is effective for troublesome hot flashes and night sweats and can help prevent bone loss. Treatment may be worthwhile when symptoms disrupt daily life, provided your personal risks are acceptable. Starting under 60 or within 10 years of menopause commonly has a more favorable balance than starting later, but neither condition guarantees suitability. [1] [3]

HRT should not be started solely to prevent heart disease or dementia. Your physician should explain what a proposed treatment is expected to help, what it is not intended to do, and how benefit will be checked. Age is part of the discussion, not an automatic prescription or refusal. [2]

Histories that can change the recommendation

Systemic hormone therapy is usually not recommended with previous breast or endometrial cancer, stroke, heart attack, blood clots or liver disease. Unexplained vaginal bleeding needs evaluation, and menopausal HRT is not for pregnancy. Some complex histories require specialist coordination rather than a standard online prescription. [3] [1]

Family history also matters, but does not mean the same thing as your own diagnosis. Bring details rather than trying to decide eligibility yourself. Nonhormonal symptom treatment remains an option when systemic hormones are unsuitable, and local vaginal treatment has a different risk discussion from systemic HRT. [2]

Treatment types do not share one risk profile

With a uterus, systemic estrogen usually needs progestogen to reduce endometrial cancer risk. Estrogen-only therapy after total hysterectomy is different from combined therapy. Combined systemic HRT is associated with increased breast-cancer risk that rises with duration; the individual context and preparation matter. [2] [3]

Oral estrogen carries more venous blood-clot risk than transdermal estrogen. A patch can be a useful choice, but it does not remove all risks. Low-dose vaginal estrogen has minimal absorption compared with systemic therapy and usually does not require added progestogen. A history of breast cancer requires a tailored local-treatment discussion. [2]

Common side effects and unexpected bleeding

Headaches, breast tenderness, bloating, nausea and spotting can occur, especially after starting or changing treatment. Mild effects often improve; severe, persistent or troublesome symptoms should prompt contact with the prescriber. Do not independently remove uterine protection to avoid an unwanted effect. [4] [3]

Bleeding expectations depend on the regimen. Current NICE guidance advises prompt medical help for unscheduled bleeding beyond the first six months of systemic HRT or beyond three months after changing dose or preparation. Heavy bleeding, pain or faintness warrants earlier help. These are review thresholds, not a reason to ignore concerning bleeding until a deadline. [2]

What “bioidentical” means

Bioidentical does not mean safer. FDA-approved estradiol and progesterone products exist; compounded hormones have not been shown to be safer or more effective than approved options and can vary in strength. Do not treat marketing language as a replacement for individualized assessment. [3]

Warning signs and ongoing review

Seek emergency care for sudden chest pain, breathlessness, stroke-like symptoms or a painful swollen leg. Severe bleeding with faintness also needs urgent assessment. Report new breast changes, unexpected bleeding and significant mood changes promptly. Regular review should reconsider symptoms, side effects and new health risks rather than renew treatment automatically. [4] [2] Source

There is no one duration that fits everyone. A review around three months and then annually is common guidance, with earlier checks when needed. Keep recommended screening current. Ask who to contact between visits and what would change the plan; those answers are more useful than a blanket claim that HRT is either safe or dangerous. [2]